Canntab Announces Agreement with Pathway Health
TORONTO, Dec. 2, 2021 /CNW/ –Ā Canntab Therapeutics LimitedĀ (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F)Ā (the “Company” or “Canntab”), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications,Ā is pleased to announce that […]